Summary
- Current Price
- As of today, COLL price is $22.77, up +1.74% on
- Current Price All-Time High
- COLL price is currently -55.17% below its historical high of $50.79 set on
- Market Cap
- COLL current market cap is $706M, down -38.13% year-over-year
- PE Ratio
- COLL current PE ratio is 18.45
- Revenue
- COLL current annual revenue is $780.57M, up +23.62% year-over-year
- Next Earnings
- The next earnings release for COLL is on
Profile
| Metric | Value |
|---|---|
| Full Name | Collegium Pharmaceutical, Inc. |
| Ticker | NASDAQ: COLL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | collegiumpharma.com |
| Employees | 357 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $22.77 | |
| Price, 1D Change | +1.74% | |
| $706M | ||
| - | ||
| 18.45 | ||
| 0.38 | ||
| $780.57M | ||
| Revenue, 1Y Change | +23.62% | |
| $1.73 | ||
| EPS, 1Y Change | -6.55% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $1.73 | ||
| EPS Estimate | $7.37 | N/A |
| EPS Est. Change | +324.84% | N/A |
| $780.57M | ||
| Revenue Estimate | $836.11M | N/A |
| Revenue Est. Change | +7.12% | N/A |
| Current Price | $22.77 | |
| Price Target | $48.00 | - |
| Price Tgt. Change | +110.80% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $6.18 | $1.86 | -69.96% | |
| $7.47 | $1.73 | -76.78% | |
| $7.37 | N/A | +324.84% | |
| $6.62 | N/A | +281.32% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $629.18M | $631.45M | +0.36% | |
| $781.48M | $780.57M | -0.12% | |
| $836.11M | N/A | +7.12% | |
| $842.51M | N/A | +7.94% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $22.77 | |
| $37.03 | ||
| $29.39 | ||
| $33.68 | ||
| $27.86 | ||
| -$1.97 | ||
| 0.38 | ||
| $1.09 | ||
| 29.95 | ||
| 28.02% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $780.57M | ||
| $1.73 | ||
| $0.00 | ||
| 59.35% | ||
| $187.08M | ||
| 23.97% | ||
| $62.87M | ||
| 8.05% | ||
| $413.16M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 3.10 | ||
| 1.57 | ||
| 1.48 | ||
| - | ||
| 5 | ||
| 0.86 |
Valuations
| Metric | Value | Date |
|---|---|---|
| 18.45 | ||
| 0.87 | ||
| 2.26 | ||
| 4.48 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $301.68M | ||
| $406.53M | ||
| $1.69B | ||
| $691.41M | ||
| $1.38B | ||
| $440.03M | ||
| $936.43M | ||
| $30.41M | ||
| $10.66M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $717.70M | ||
| $276.17M | ||
| $317.31M | ||
| $284.80M | ||
| $226.07M | ||
| $0.00 | ||
| $29.75M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $329.32M | ||
| -$63.53M | ||
| -$110.25M | ||
| $1.74M | ||
| $327.58M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Truist Securities | → | |
| Leerink Partners | ||
| Barclays | → | |
| Piper Sandler | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| Needham | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| Barclays | → |
Analyst sentiment
Institutional ownership
Screeners with COLL
FAQ
- What is the ticker symbol for Collegium Pharmaceutical, Inc.?
- The ticker symbol for Collegium Pharmaceutical, Inc. is NASDAQ:COLL
- Does Collegium Pharmaceutical, Inc. pay dividends?
- No, Collegium Pharmaceutical, Inc. does not pay dividends
- What sector is Collegium Pharmaceutical, Inc. in?
- Collegium Pharmaceutical, Inc. is in the Healthcare sector
- What industry is Collegium Pharmaceutical, Inc. in?
- Collegium Pharmaceutical, Inc. is in the Specialty & Generic Drug Manufacturers industry
- What country is Collegium Pharmaceutical, Inc. based in?
- Collegium Pharmaceutical, Inc. is headquartered in United States
- When did Collegium Pharmaceutical, Inc. go public?
- Collegium Pharmaceutical, Inc. initial public offering (IPO) was on May 7, 2015
- Is Collegium Pharmaceutical, Inc. in the S&P 500?
- No, Collegium Pharmaceutical, Inc. is not included in the S&P 500 index
- Is Collegium Pharmaceutical, Inc. in the NASDAQ 100?
- No, Collegium Pharmaceutical, Inc. is not included in the NASDAQ 100 index
- Is Collegium Pharmaceutical, Inc. in the Dow Jones?
- No, Collegium Pharmaceutical, Inc. is not included in the Dow Jones index
- When was Collegium Pharmaceutical, Inc. last earnings report?
- Collegium Pharmaceutical, Inc.'s most recent earnings report was on August 6, 2026
- When does Collegium Pharmaceutical, Inc. report earnings?
- The next expected earnings date for Collegium Pharmaceutical, Inc. is November 5, 2026
Data Sources & References
- COLL Official Website www.collegiumpharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1267565/000162828026011992/0001628280-26-011992-index.htm
- COLL Profile on Yahoo Finance finance.yahoo.com/quote/COLL
- COLL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/coll